- Design
- Cross-sectional analysis within a prospective cohort (DCCT/EDIC)
- Population
- 963 adults with type 1 diabetes, mean age 64, mean duration 43 years
- Primary outcome
- Prevalence of sleep apnoea risk, poor sleep quality and daytime sleepiness
- Effect
- 64% intermediate/high OSA risk; 43% poor sleep; 15–20% higher odds per 1% HbA1c
Diabetes Care reported a cross-sectional questionnaire study in 963 DCCT/EDIC participants, mean age 64 and mean diabetes duration 43 years. Validated instruments measured sleep apnoea risk (STOP-Bang), sleep quality (Pittsburgh Sleep Quality Index) and daytime sleepiness (Epworth).
29% already had diagnosed sleep apnoea and 19% used positive airway pressure. 64% screened at intermediate or high risk, 43% had poor sleep quality and 10% daytime sleepiness. Each 1% higher HbA1c was associated with 15–20% higher odds of any sleep problem. Cardiovascular autonomic neuropathy was linked to apnoea risk, and albuminuria and severe hypoglycaemia to poor sleep quality.
Sleep apnoea is usually framed as a type 2 diabetes and obesity problem. These data suggest older people with type 1 diabetes carry a high burden too, and much of it may be unrecognised. The design cannot say whether poor glycaemia disturbs sleep or the reverse.
Ask about snoring, witnessed apnoeas and sleep quality in older type 1 patients, particularly those with autonomic neuropathy or recurrent severe hypoglycaemia.
- Ask older type 1 patients about snoring, witnessed apnoeas and unrefreshing sleep
- Use STOP-Bang as a quick screen; a score of 3 or more warrants a sleep study referral
- Consider sleep apnoea when a patient has cardiovascular autonomic neuropathy
- Ask about sleep quality in patients with recurrent severe hypoglycaemia or albuminuria
Why it matters
Sleep apnoea is not only a type 2 diabetes and obesity problem.
Don't overread it
This was cross-sectional — it cannot show that poor glycaemia causes sleep problems or that treating sleep improves HbA1c.
The statistics, in plain English
"Intermediate or high risk" on STOP-Bang is a screening result, not a diagnosis; the tool is sensitive but over-calls, so the true prevalence is lower than 64%. The HbA1c link is an adjusted association from one time point.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free